Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Aki Nakamura-Takahashi"'
Autor:
Akihiro Hasegawa, Aki Nakamura-Takahashi, Masataka Kasahara, Nana Saso, Sonoko Narisawa, José Luis Millán, Osamu Samura, Haruhiko Sago, Aikou Okamoto, Akihiro Umezawa
Publikováno v:
Regenerative Therapy, Vol 18, Iss , Pp 168-175 (2021)
Hypophosphatasia (HPP) is a congenital skeletal disease. Impairment of bone mineralization and seizures are due to a deficiency of tissue-nonspecific alkaline phosphatase (TNAP). Enzyme replacement therapy (ERT) is available as a highly successful tr
Externí odkaz:
https://doaj.org/article/c9dde3dbb11342f7a7366c05cf01dec6
Autor:
Yuko Nitahara-Kasahara, Shuji Mizumoto, Yukiko U. Inoue, Shota Saka, Guillermo Posadas-Herrera, Aki Nakamura-Takahashi, Yuki Takahashi, Ayana Hashimoto, Kohei Konishi, Shinji Miyata, Chiaki Masuda, Emi Matsumoto, Yasunobu Maruoka, Takahiro Yoshizawa, Toshiki Tanase, Takayoshi Inoue, Shuhei Yamada, Yoshihiro Nomura, Shin'ichi Takeda, Atsushi Watanabe, Tomoki Kosho, Takashi Okada
Publikováno v:
Disease Models & Mechanisms, Vol 14, Iss 12 (2021)
Musculocontractural Ehlers-Danlos syndrome (mcEDS) is caused by generalized depletion of dermatan sulfate (DS) due to biallelic pathogenic variants in CHST14 encoding dermatan 4-O-sulfotransferase 1 (D4ST1) (mcEDS-CHST14). Here, we generated mouse mo
Externí odkaz:
https://doaj.org/article/18ac308ec99e4737bca148fc2a47dc8c
Autor:
Yuko Nitahara-Kasahara, Guillermo Posadas-Herrera, Shuji Mizumoto, Aki Nakamura-Takahashi, Yukiko U. Inoue, Takayoshi Inoue, Yoshihiro Nomura, Shin’ichi Takeda, Shuhei Yamada, Tomoki Kosho, Takashi Okada
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Carbohydrate sulfotransferase 14 (CHST14) encodes dermatan 4-O-sulfotransferase 1, a critical enzyme for dermatan sulfate (DS) biosynthesis. Musculocontractural Ehlers-Danlos syndrome (mcEDS) is associated with biallelic pathogenic variants of CHST14
Externí odkaz:
https://doaj.org/article/628c0d523aa044b4b5618df49eddeeef
Autor:
Kota Sowa, Chikako Nito, Masataka Nakajima, Satoshi Suda, Yasuhiro Nishiyama, Yuki Sakamoto, Yuko Nitahara-Kasahara, Aki Nakamura-Takahashi, Masayuki Ueda, Kazumi Kimura, Takashi Okada
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 10, Iss , Pp 281-290 (2018)
Hepatocyte growth factor (HGF) has neuroprotective effects against ischemia-induced injuries. Dental pulp stem cell (DPSC) transplantation attenuates tissue injury in the brain of rats with post-transient middle cerebral artery occlusion. We sought t
Externí odkaz:
https://doaj.org/article/1a3ab391f59241b8b860929d6858b436
Autor:
Ryo Ikeue, Aki Nakamura-Takahashi, Yuko Nitahara-Kasahara, Atsushi Watanabe, Takashi Muramatsu, Toru Sato, Takashi Okada
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 10, Iss , Pp 361-370 (2018)
Hypophosphatasia is an inherited disease caused by mutations in the gene encoding tissue-nonspecific alkaline phosphatase (TNALP), the major symptom of which is hypomineralization of the bones and teeth. We had recently demonstrated that TNALP-defici
Externí odkaz:
https://doaj.org/article/cda2464d2fb5447baed81ec3eacbf835
Autor:
Masataka Nakajima, Chikako Nito, Kota Sowa, Satoshi Suda, Yasuhiro Nishiyama, Aki Nakamura-Takahashi, Yuko Nitahara-Kasahara, Kiwamu Imagawa, Tohru Hirato, Masayuki Ueda, Kazumi Kimura, Takashi Okada
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 102-111 (2017)
Interleukin (IL)-10 is a contributing factor to neuroprotection of mesenchymal stem cell (MSC) transplantation after ischemic stroke. Our aim was to increase therapeutic effects by combining MSCs and ex vivo IL-10 gene transfer with an adeno-associat
Externí odkaz:
https://doaj.org/article/50cd340585d2420d99166b436cb24786
Autor:
Aki Nakamura-Takahashi, Koichi Miyake, Atsushi Watanabe, Yukihiko Hirai, Osamu Iijima, Noriko Miyake, Kumi Adachi, Yuko Nitahara-Kasahara, Hideaki Kinoshita, Taku Noguchi, Shinichi Abe, Sonoko Narisawa, Jose Luis Millán, Takashi Shimada, Takashi Okada
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 3, Iss C (2016)
Hypophosphatasia (HPP) is an inherited disease caused by genetic mutations in the gene encoding tissue-nonspecific alkaline phosphatase (TNALP). This results in defects in bone and tooth mineralization. We recently demonstrated that TNALP-deficient (
Externí odkaz:
https://doaj.org/article/b854796ff45a455191ade5d1a6c16743
Autor:
Masataka Kasahara, Haruhiko Sago, Aki Nakamura-Takahashi, Nana Saso, Aikou Okamoto, Osamu Samura, José Luis Millán, Sonoko Narisawa, Akihiro Hasegawa, Akihiro Umezawa
Publikováno v:
Regenerative Therapy, Vol 18, Iss, Pp 168-175 (2021)
Regenerative Therapy
Regenerative Therapy
Hypophosphatasia (HPP) is a congenital skeletal disease. Impairment of bone mineralization and seizures are due to a deficiency of tissue-nonspecific alkaline phosphatase (TNAP). Enzyme replacement therapy (ERT) is available as a highly successful tr
Autor:
Kaori Yoshida, Satoshi Ishizuka, Aki Nakamura-Takahashi, Akihiro Hasegawa, Akihiro Umezawa, Kyotaro Koshika, Tatsuya Ichinohe, Masataka Kasahara
Publikováno v:
European Journal of Medical Genetics. 66:104787
Autor:
Chiaki Masuda, Yuki Takahashi, Atsushi Watanabe, Shota Saka, Yukiko U. Inoue, Shuji Mizumoto, Takashi Okada, Kohei Konishi, Toshiki Tanase, Shinji Miyata, Aki Nakamura-Takahashi, Yuko Nitahara-Kasahara, Takahiro Yoshizawa, Shuhei Yamada, Takayoshi Inoue, Yasunobu Maruoka, Guillermo Posadas-Herrera, Emi Matsumoto, Tomoki Kosho, Yoshihiro Nomura, Takeda Shin'ichi, Ayana Hashimoto
Publikováno v:
Disease Models & Mechanisms
article-version (VoR) Version of Record
Disease Models & Mechanisms, Vol 14, Iss 12 (2021)
article-version (VoR) Version of Record
Disease Models & Mechanisms, Vol 14, Iss 12 (2021)
Musculocontractural Ehlers-Danlos syndrome (mcEDS) is caused by generalized depletion of dermatan sulfate (DS) due to biallelic pathogenic variants in CHST14 encoding dermatan 4-O-sulfotransferase 1 (D4ST1) (mcEDS-CHST14). Here, we generated mouse mo